ConductScience.org, home

Paper36980565

Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies.

Kitsel Y and 3 others. Cancers (Basel), 2023. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies. Papers, record 36980565. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980565

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2023-05-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kitsel YYuliya
2Cooke TTimothyhttps://orcid.org/0009-0009-1014-8627
3Sotirchos VVlasioshttps://orcid.org/0000-0001-7278-1369
4Sofocleous CTConstantinos Thttps://orcid.org/0000-0002-3142-1399

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References189

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125942399BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.Br J Cancer2015https://conductscience.org/library/papers/25942399PubMed
221514841CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.J Vasc Interv Radiol2011https://conductscience.org/library/papers/21514841PubMed
327907852The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials.Eur J Cancer2017https://conductscience.org/library/papers/27907852PubMed
421900593Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab.Sci Transl Med2011https://conductscience.org/library/papers/21900593PubMed
535246503Colorectal liver metastasis: molecular mechanism and interventional therapy.Signal Transduct Target Ther2022https://conductscience.org/library/papers/35246503PubMed
631056702
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Ann Oncol2019https://conductscience.org/library/papers/31056702PubMed
736262749Study of KRAS-Related miRNA Expression in Colorectal Cancer.Cancer Manag Res2022https://conductscience.org/library/papers/36262749PubMed
818676755K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.Clin Cancer Res2008https://conductscience.org/library/papers/18676755PubMed
920567019
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
J Clin Oncol2010https://conductscience.org/library/papers/20567019PubMed
1018757341Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.J Clin Oncol2008https://conductscience.org/library/papers/18757341PubMed
1128632865Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.JAMA2017https://conductscience.org/library/papers/28632865PubMed
1236268887The Role of 18F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors.Mol Imaging Radionucl Ther2022https://conductscience.org/library/papers/36268887PubMed
1332779054
Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases.
Ann Surg Oncol2020https://conductscience.org/library/papers/32779054PubMed
1429728604Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.Nat Commun2018https://conductscience.org/library/papers/29728604PubMed
1527384594Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.AJR Am J Roentgenol2016https://conductscience.org/library/papers/27384594PubMed
1619571295BRAF mutation in metastatic colorectal cancer.N Engl J Med2009https://conductscience.org/library/papers/19571295PubMed
1722586653A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.Cancer Discov2011https://conductscience.org/library/papers/22586653PubMed
1835780916Prognostic and predictive molecular biomarkers in advanced colorectal cancer.Pharmacol Ther2022https://conductscience.org/library/papers/35780916PubMed
1927334313RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases.J Gastrointest Surg2017https://conductscience.org/library/papers/27334313PubMed
2033005411Prognostic and predictive value of circulating DNA for hepatic arterial infusion of chemotherapy for patients with colorectal cancer liver metastases.Mol Clin Oncol2020https://conductscience.org/library/papers/33005411PubMed

See all 189 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42367489Metabolic and Inflammatory Markers of Fatty Liver As Associated Factors of Hepatic Metastatic Spread in Colorectal Cancer.Cureus2026https://conductscience.org/library/papers/42367489PubMed
41809353Prognostic value of primary tumor site in surgery for colorectal liver metastases.World J Gastrointest Surg2026https://conductscience.org/library/papers/41809353PubMed
41113971Prediction of pediatric Wilms tumor recurrence using interpretable machine learning models: insights from a 20-year real-world study and the prognostic value of Ki-67.Am J Cancer Res2025https://conductscience.org/library/papers/41113971PubMed
41007745Interventional Oncology for Colorectal Liver Metastases: From Local Cure to Salvage Therapy.Biomedicines2025https://conductscience.org/library/papers/41007745PubMed
40653800Utilizing intratumoral and peritumoral ultrasound radiomics for predicting KRAS gene mutation status in rectal cancer patients.J Appl Clin Med Phys2025https://conductscience.org/library/papers/40653800PubMed
40303874Liver Transplantation for Non-hepatocellular Carcinoma: The Role of Immune Checkpoint Inhibitors.J Clin Exp Hepatol2025https://conductscience.org/library/papers/40303874PubMed
39690384Comparison of Intratumoral and Peritumoral Deep Learning, Radiomics, and Fusion Models for Predicting KRAS Gene Mutations in Rectal Cancer Based on Endorectal Ultrasound Imaging.Ann Surg Oncol2025https://conductscience.org/library/papers/39690384PubMed
39183242
Clinical value of sequential circulating tumor DNA analysis using next-generation sequencing and epigenetic modifications for guiding thermal ablation for colorectal cancer metastases: a prospective study.
Radiol Med2024https://conductscience.org/library/papers/39183242PubMed
39172317Patterns and Predictors of Recurrence After Curative Resection of Colorectal Liver Metastasis (CRLM).J Gastrointest Cancer2024https://conductscience.org/library/papers/39172317PubMed
38239646Nomogram for predicting occurrence and prognosis of liver metastasis in elderly colorectal cancer patients: a population-based study.Front Oncol2023https://conductscience.org/library/papers/38239646PubMed
380896533D Printing for Cancer Diagnosis: What Unique Advantages Are Gained?ACS Mater Au2023https://conductscience.org/library/papers/38089653PubMed
37240247Gene Expression Changes in Cytokine and Chemokine Receptors in Association with Melanoma Liver Metastasis.Int J Mol Sci2023https://conductscience.org/library/papers/37240247PubMed

Download CSV of cited by

Genes43

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACVR2A92PubTator's text mininghttps://conductscience.org/library/genes/92NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
CILK122858PubTator's text mininghttps://conductscience.org/library/genes/22858NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FBXW755294PubTator's text mininghttps://conductscience.org/library/genes/55294NCBI Gene
FLT12321PubTator's text mininghttps://conductscience.org/library/genes/2321NCBI Gene
HMGB13146PubTator's text mininghttps://conductscience.org/library/genes/3146NCBI Gene
HRAS3265PubTator's text mininghttps://conductscience.org/library/genes/3265NCBI Gene
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MLH14292PubTator's text mininghttps://conductscience.org/library/genes/4292NCBI Gene

See all 43 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980565

GET https://conductscience.org/api/papers/v1/36980565/references?page=2